Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study

Figure 2

Classification of tumours from an independent validation set according to the molecular signatures that specify the defined subgroups. The validation set (109 tumours) included 24 luminal A, 19 luminal B, 5 normal-like, 8 ERBB2, 20 basal and 33 unclassified tumours. None of the independent tumours were classified into subgroups 5 and 12 as defined by hierarchical clustering and Chi2 analysis.

Back to article page